Annals of Oncology Advance Access originally published online on May 27, 2009
Annals of Oncology 2009 20(9):1517-1521; doi:10.1093/annonc/mdp023
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gastrointestinal tumors |
Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant
1 Departments of Medicine and Epidemiology, College of Physicians and Surgeons, and the Mailman School of Public Health, Columbia University, New York, NY, USA
2 Integrated Cancer Prevention Center, Tel-Aviv Sourasky Medical Center
3 Department of Sackler Faculty of Medicine
4 Department of Oncology
5 Gastroenterology, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel Aviv, Israel
* Correspondence to: Dr N. Arber, Integrated Cancer Prevention Center, Tel-Aviv Sourasky Medical Center, 6 Weizmann Street, Tel-Aviv 64236, Israel. Tel: +972-3-697-4968; Fax: +972-3-695-0339; E-mail: narber{at}post.tau.ac.il
Background: Reports of the risk of colorectal neoplasia associated with a variant of the adenomatous polyposis coli (APC E1317Q) gene are conflicting. Using a case–control design, we investigated this relationship within a clinic-based cohort followed through the Integrated Cancer Prevention Center and the Tel-Aviv Sourasky Medical Center.
Materials and Methods: All study subjects were tested for the APC E1317Q variant at enrollment. Subjects underwent colonoscopic evaluation (±biopsy and/or polypectomy) and had cancer history and colorectal neoplasia risk factors assessed. The crude and adjusted risks of neoplasia associated with the E1317Q variant were calculated.
Results: The prevalence of the E1317Q variant was 1.4% in the entire study sample and 3.2% in Sephardic Jews. E1317Q was more prevalent among cases: 15 of 458 (3.3%) cases were carriers compared with 11 of 1431 (0.8%) controls [odds ratio (OR) 4.4, 95% CI 2.0–9.6]. When stratified by neoplasia type, adenoma risk was significantly elevated in carriers (OR 4.1, 95% CI 1.8–9.4) but colorectal cancer risk was not (OR 2.1, 95% CI 0.8–5.3). After adjustment, the E1317Q variant remained a significant predictor of colorectal adenoma (OR 4.6, 95% CI 2.0–10.8).
Conclusions: The APC E1317Q variant is associated with colorectal neoplasia, particularly colorectal adenomas, but further studies are still needed. Variant prevalence is elevated in Sephardic Jews.
Key words: APC gene, colorectal cancer, E1317Q, hereditary risk
Received for publication October 15, 2008. Revision received January 14, 2009. Accepted for publication January 16, 2009.
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in Ann Oncol:
- in this issue
Ann Oncol 2009 20: 1453.[Extract] [Full Text]